Decitabine in Treating Patients With Myelofibrosis
NCT00095784
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
21
Enrollment
NIH
Sponsor class
Conditions
Primary Myelofibrosis
Secondary Myelofibrosis
Interventions
DRUG:
Decitabine
OTHER:
Laboratory Biomarker Analysis
Sponsor
National Cancer Institute (NCI)